img

Global Loratadine API Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Loratadine API Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Loratadine API market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Loratadine API is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Loratadine API is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Loratadine API is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Loratadine API include Merck Group, Cadila Pharmaceuticals, Morepen, Ultratech India Limited, Vasudha Pharma Chem, Hetero Drugs Ltd, Mylan, Changzhou Yabang and Shaanxi Hanjiang, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Loratadine API, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Loratadine API by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Loratadine API market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Loratadine API market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Merck Group
Cadila Pharmaceuticals
Morepen
Ultratech India Limited
Vasudha Pharma Chem
Hetero Drugs Ltd
Mylan
Changzhou Yabang
Shaanxi Hanjiang
Inke, S.A.
Argon Drugs
Shenzhen Haibin Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Changzhou Fangyuan Pharmaceutical
By Type
USP Standards Grade
EP Standards Grade
Pharmaceutical Standards Grade
Others
By Application
Loratadine Tablet
Loratadine Capsules
Loratadine Syrup
Dry Suspension
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Loratadine API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Loratadine API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Loratadine API sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Loratadine API Definition
1.2 Market by Type
1.2.1 Global Loratadine API Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 USP Standards Grade
1.2.3 EP Standards Grade
1.2.4 Pharmaceutical Standards Grade
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Loratadine API Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Loratadine Tablet
1.3.3 Loratadine Capsules
1.3.4 Loratadine Syrup
1.3.5 Dry Suspension
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Loratadine API Sales
2.1 Global Loratadine API Revenue Estimates and Forecasts 2018-2034
2.2 Global Loratadine API Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Loratadine API Revenue by Region
2.3.1 Global Loratadine API Revenue by Region (2018-2024)
2.3.2 Global Loratadine API Revenue by Region (2024-2034)
2.4 Global Loratadine API Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Loratadine API Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Loratadine API Sales Quantity by Region
2.6.1 Global Loratadine API Sales Quantity by Region (2018-2024)
2.6.2 Global Loratadine API Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Loratadine API Sales Quantity by Manufacturers
3.1.1 Global Loratadine API Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Loratadine API Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Loratadine API Sales in 2022
3.2 Global Loratadine API Revenue by Manufacturers
3.2.1 Global Loratadine API Revenue by Manufacturers (2018-2024)
3.2.2 Global Loratadine API Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Loratadine API Revenue in 2022
3.3 Global Loratadine API Sales Price by Manufacturers
3.4 Global Key Players of Loratadine API, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Loratadine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Loratadine API, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Loratadine API, Product Offered and Application
3.8 Global Key Manufacturers of Loratadine API, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Loratadine API Sales Quantity by Type
4.1.1 Global Loratadine API Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Loratadine API Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Loratadine API Sales Quantity Market Share by Type (2018-2034)
4.2 Global Loratadine API Revenue by Type
4.2.1 Global Loratadine API Historical Revenue by Type (2018-2024)
4.2.2 Global Loratadine API Forecasted Revenue by Type (2024-2034)
4.2.3 Global Loratadine API Revenue Market Share by Type (2018-2034)
4.3 Global Loratadine API Price by Type
4.3.1 Global Loratadine API Price by Type (2018-2024)
4.3.2 Global Loratadine API Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Loratadine API Sales Quantity by Application
5.1.1 Global Loratadine API Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Loratadine API Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Loratadine API Sales Quantity Market Share by Application (2018-2034)
5.2 Global Loratadine API Revenue by Application
5.2.1 Global Loratadine API Historical Revenue by Application (2018-2024)
5.2.2 Global Loratadine API Forecasted Revenue by Application (2024-2034)
5.2.3 Global Loratadine API Revenue Market Share by Application (2018-2034)
5.3 Global Loratadine API Price by Application
5.3.1 Global Loratadine API Price by Application (2018-2024)
5.3.2 Global Loratadine API Price Forecast by Application (2024-2034)
6 North America
6.1 North America Loratadine API Sales by Company
6.1.1 North America Loratadine API Revenue by Company (2018-2024)
6.1.2 North America Loratadine API Sales Quantity by Company (2018-2024)
6.2 North America Loratadine API Market Size by Type
6.2.1 North America Loratadine API Sales Quantity by Type (2018-2034)
6.2.2 North America Loratadine API Revenue by Type (2018-2034)
6.3 North America Loratadine API Market Size by Application
6.3.1 North America Loratadine API Sales Quantity by Application (2018-2034)
6.3.2 North America Loratadine API Revenue by Application (2018-2034)
6.4 North America Loratadine API Market Size by Country
6.4.1 North America Loratadine API Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Loratadine API Revenue by Country (2018-2034)
6.4.3 North America Loratadine API Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Loratadine API Sales by Company
7.1.1 Europe Loratadine API Sales Quantity by Company (2018-2024)
7.1.2 Europe Loratadine API Revenue by Company (2018-2024)
7.2 Europe Loratadine API Market Size by Type
7.2.1 Europe Loratadine API Sales Quantity by Type (2018-2034)
7.2.2 Europe Loratadine API Revenue by Type (2018-2034)
7.3 Europe Loratadine API Market Size by Application
7.3.1 Europe Loratadine API Sales Quantity by Application (2018-2034)
7.3.2 Europe Loratadine API Revenue by Application (2018-2034)
7.4 Europe Loratadine API Market Size by Country
7.4.1 Europe Loratadine API Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Loratadine API Revenue by Country (2018-2034)
7.4.3 Europe Loratadine API Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Loratadine API Sales by Company
8.1.1 China Loratadine API Sales Quantity by Company (2018-2024)
8.1.2 China Loratadine API Revenue by Company (2018-2024)
8.2 China Loratadine API Market Size by Type
8.2.1 China Loratadine API Sales Quantity by Type (2018-2034)
8.2.2 China Loratadine API Revenue by Type (2018-2034)
8.3 China Loratadine API Market Size by Application
8.3.1 China Loratadine API Sales Quantity by Application (2018-2034)
8.3.2 China Loratadine API Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Loratadine API Sales by Company
9.1.1 APAC Loratadine API Sales Quantity by Company (2018-2024)
9.1.2 APAC Loratadine API Revenue by Company (2018-2024)
9.2 APAC Loratadine API Market Size by Type
9.2.1 APAC Loratadine API Sales Quantity by Type (2018-2034)
9.2.2 APAC Loratadine API Revenue by Type (2018-2034)
9.3 APAC Loratadine API Market Size by Application
9.3.1 APAC Loratadine API Sales Quantity by Application (2018-2034)
9.3.2 APAC Loratadine API Revenue by Application (2018-2034)
9.4 APAC Loratadine API Market Size by Region
9.4.1 APAC Loratadine API Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Loratadine API Revenue by Region (2018-2034)
9.4.3 APAC Loratadine API Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Loratadine API Sales by Company
10.1.1 Middle East, Africa and Latin America Loratadine API Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Loratadine API Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Loratadine API Market Size by Type
10.2.1 Middle East, Africa and Latin America Loratadine API Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Loratadine API Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Loratadine API Market Size by Application
10.3.1 Middle East, Africa and Latin America Loratadine API Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Loratadine API Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Loratadine API Market Size by Country
10.4.1 Middle East, Africa and Latin America Loratadine API Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Loratadine API Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Loratadine API Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck Group
11.1.1 Merck Group Company Information
11.1.2 Merck Group Overview
11.1.3 Merck Group Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck Group Loratadine API Products and Services
11.1.5 Merck Group Loratadine API SWOT Analysis
11.1.6 Merck Group Recent Developments
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Company Information
11.2.2 Cadila Pharmaceuticals Overview
11.2.3 Cadila Pharmaceuticals Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Cadila Pharmaceuticals Loratadine API Products and Services
11.2.5 Cadila Pharmaceuticals Loratadine API SWOT Analysis
11.2.6 Cadila Pharmaceuticals Recent Developments
11.3 Morepen
11.3.1 Morepen Company Information
11.3.2 Morepen Overview
11.3.3 Morepen Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Morepen Loratadine API Products and Services
11.3.5 Morepen Loratadine API SWOT Analysis
11.3.6 Morepen Recent Developments
11.4 Ultratech India Limited
11.4.1 Ultratech India Limited Company Information
11.4.2 Ultratech India Limited Overview
11.4.3 Ultratech India Limited Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Ultratech India Limited Loratadine API Products and Services
11.4.5 Ultratech India Limited Loratadine API SWOT Analysis
11.4.6 Ultratech India Limited Recent Developments
11.5 Vasudha Pharma Chem
11.5.1 Vasudha Pharma Chem Company Information
11.5.2 Vasudha Pharma Chem Overview
11.5.3 Vasudha Pharma Chem Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Vasudha Pharma Chem Loratadine API Products and Services
11.5.5 Vasudha Pharma Chem Loratadine API SWOT Analysis
11.5.6 Vasudha Pharma Chem Recent Developments
11.6 Hetero Drugs Ltd
11.6.1 Hetero Drugs Ltd Company Information
11.6.2 Hetero Drugs Ltd Overview
11.6.3 Hetero Drugs Ltd Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Hetero Drugs Ltd Loratadine API Products and Services
11.6.5 Hetero Drugs Ltd Loratadine API SWOT Analysis
11.6.6 Hetero Drugs Ltd Recent Developments
11.7 Mylan
11.7.1 Mylan Company Information
11.7.2 Mylan Overview
11.7.3 Mylan Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Mylan Loratadine API Products and Services
11.7.5 Mylan Loratadine API SWOT Analysis
11.7.6 Mylan Recent Developments
11.8 Changzhou Yabang
11.8.1 Changzhou Yabang Company Information
11.8.2 Changzhou Yabang Overview
11.8.3 Changzhou Yabang Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Changzhou Yabang Loratadine API Products and Services
11.8.5 Changzhou Yabang Loratadine API SWOT Analysis
11.8.6 Changzhou Yabang Recent Developments
11.9 Shaanxi Hanjiang
11.9.1 Shaanxi Hanjiang Company Information
11.9.2 Shaanxi Hanjiang Overview
11.9.3 Shaanxi Hanjiang Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Shaanxi Hanjiang Loratadine API Products and Services
11.9.5 Shaanxi Hanjiang Loratadine API SWOT Analysis
11.9.6 Shaanxi Hanjiang Recent Developments
11.10 Inke, S.A.
11.10.1 Inke, S.A. Company Information
11.10.2 Inke, S.A. Overview
11.10.3 Inke, S.A. Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Inke, S.A. Loratadine API Products and Services
11.10.5 Inke, S.A. Loratadine API SWOT Analysis
11.10.6 Inke, S.A. Recent Developments
11.11 Argon Drugs
11.11.1 Argon Drugs Company Information
11.11.2 Argon Drugs Overview
11.11.3 Argon Drugs Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Argon Drugs Loratadine API Products and Services
11.11.5 Argon Drugs Recent Developments
11.12 Shenzhen Haibin Pharmaceutical
11.12.1 Shenzhen Haibin Pharmaceutical Company Information
11.12.2 Shenzhen Haibin Pharmaceutical Overview
11.12.3 Shenzhen Haibin Pharmaceutical Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Shenzhen Haibin Pharmaceutical Loratadine API Products and Services
11.12.5 Shenzhen Haibin Pharmaceutical Recent Developments
11.13 Shenzhen Salubris Pharmaceuticals
11.13.1 Shenzhen Salubris Pharmaceuticals Company Information
11.13.2 Shenzhen Salubris Pharmaceuticals Overview
11.13.3 Shenzhen Salubris Pharmaceuticals Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Shenzhen Salubris Pharmaceuticals Loratadine API Products and Services
11.13.5 Shenzhen Salubris Pharmaceuticals Recent Developments
11.14 Changzhou Fangyuan Pharmaceutical
11.14.1 Changzhou Fangyuan Pharmaceutical Company Information
11.14.2 Changzhou Fangyuan Pharmaceutical Overview
11.14.3 Changzhou Fangyuan Pharmaceutical Loratadine API Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Changzhou Fangyuan Pharmaceutical Loratadine API Products and Services
11.14.5 Changzhou Fangyuan Pharmaceutical Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Loratadine API Value Chain Analysis
12.2 Loratadine API Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Loratadine API Production Mode & Process
12.4 Loratadine API Sales and Marketing
12.4.1 Loratadine API Sales Channels
12.4.2 Loratadine API Distributors
12.5 Loratadine API Customers
13 Market Dynamics
13.1 Loratadine API Industry Trends
13.2 Loratadine API Market Drivers
13.3 Loratadine API Market Challenges
13.4 Loratadine API Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Loratadine API Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of USP Standards Grade
Table 3. Major Manufacturers of EP Standards Grade
Table 4. Major Manufacturers of Pharmaceutical Standards Grade
Table 5. Major Manufacturers of Others
Table 6. Global Loratadine API Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Loratadine API Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Loratadine API Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Loratadine API Revenue Market Share by Region (2018-2024)
Table 10. Global Loratadine API Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Loratadine API Revenue Market Share by Region (2024-2034)
Table 12. Global Loratadine API Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 13. Global Loratadine API Sales by Region (2018-2024) & (K MT)
Table 14. Global Loratadine API Sales Market Share by Region (2018-2024)
Table 15. Global Loratadine API Sales by Region (2024-2034) & (K MT)
Table 16. Global Loratadine API Sales Market Share by Region (2024-2034)
Table 17. Global Loratadine API Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 18. Global Loratadine API Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Loratadine API Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Loratadine API Revenue Share by Manufacturers (2018-2024)
Table 21. Global Loratadine API Price by Manufacturers 2018-2024 (USD/MT)
Table 22. Global Key Players of Loratadine API, Industry Ranking, 2021 VS 2022
Table 23. Global Loratadine API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Loratadine API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Loratadine API as of 2022)
Table 25. Global Key Manufacturers of Loratadine API, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Loratadine API, Product Offered and Application
Table 27. Global Key Manufacturers of Loratadine API, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Loratadine API Sales Quantity by Type (2018-2024) & (K MT)
Table 30. Global Loratadine API Sales Quantity by Type (2024-2034) & (K MT)
Table 31. Global Loratadine API Sales Quantity Share by Type (2018-2024)
Table 32. Global Loratadine API Sales Quantity Share by Type (2024-2034)
Table 33. Global Loratadine API Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Loratadine API Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Loratadine API Revenue Share by Type (2018-2024)
Table 36. Global Loratadine API Revenue Share by Type (2024-2034)
Table 37. Loratadine API Price by Type (2018-2024) & (USD/MT)
Table 38. Global Loratadine API Price Forecast by Type (2024-2034) & (USD/MT)
Table 39. Global Loratadine API Sales Quantity by Application (2018-2024) & (K MT)
Table 40. Global Loratadine API Sales Quantity by Application (2024-2034) & (K MT)
Table 41. Global Loratadine API Sales Quantity Share by Application (2018-2024)
Table 42. Global Loratadine API Sales Quantity Share by Application (2024-2034)
Table 43. Global Loratadine API Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Loratadine API Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Loratadine API Revenue Share by Application (2018-2024)
Table 46. Global Loratadine API Revenue Share by Application (2024-2034)
Table 47. Loratadine API Price by Application (2018-2024) & (USD/MT)
Table 48. Global Loratadine API Price Forecast by Application (2024-2034) & (USD/MT)
Table 49. North America Loratadine API Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Loratadine API Sales Quantity by Company (2018-2024) & (K MT)
Table 51. North America Loratadine API Sales Quantity by Type (2018-2024) & (K MT)
Table 52. North America Loratadine API Sales Quantity by Type (2024-2034) & (K MT)
Table 53. North America Loratadine API Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Loratadine API Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Loratadine API Sales Quantity by Application (2018-2024) & (K MT)
Table 56. North America Loratadine API Sales Quantity by Application (2024-2034) & (K MT)
Table 57. North America Loratadine API Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Loratadine API Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Loratadine API Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Loratadine API Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Loratadine API Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Loratadine API Sales Quantity by Country (2018-2024) & (K MT)
Table 63. North America Loratadine API Sales Quantity by Country (2024-2034) & (K MT)
Table 64. Europe Loratadine API Sales Quantity by Company (2018-2024) & (K MT)
Table 65. Europe Loratadine API Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Loratadine API Sales Quantity by Type (2018-2024) & (K MT)
Table 67. Europe Loratadine API Sales Quantity by Type (2024-2034) & (K MT)
Table 68. Europe Loratadine API Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Loratadine API Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Loratadine API Sales Quantity by Application (2018-2024) & (K MT)
Table 71. Europe Loratadine API Sales Quantity by Application (2024-2034) & (K MT)
Table 72. Europe Loratadine API Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Loratadine API Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Loratadine API Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Loratadine API Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Loratadine API Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Loratadine API Sales Quantity by Country (2018-2024) & (K MT)
Table 78. Europe Loratadine API Sales Quantity by Country (2024-2034) & (K MT)
Table 79. China Loratadine API Sales Quantity by Company (2018-2024) & (K MT)
Table 80. China Loratadine API Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Loratadine API Sales Quantity by Type (2018-2024) & (K MT)
Table 82. China Loratadine API Sales Quantity by Type (2024-2034) & (K MT)
Table 83. China Loratadine API Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Loratadine API Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Loratadine API Sales Quantity by Application (2018-2024) & (K MT)
Table 86. China Loratadine API Sales Quantity by Application (2024-2034) & (K MT)
Table 87. China Loratadine API Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Loratadine API Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Loratadine API Sales Quantity by Company (2018-2024) & (K MT)
Table 90. APAC Loratadine API Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Loratadine API Sales Quantity by Type (2018-2024) & (K MT)
Table 92. APAC Loratadine API Sales Quantity by Type (2024-2034) & (K MT)
Table 93. APAC Loratadine API Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Loratadine API Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Loratadine API Sales Quantity by Application (2018-2024) & (K MT)
Table 96. APAC Loratadine API Sales Quantity by Application (2024-2034) & (K MT)
Table 97. APAC Loratadine API Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Loratadine API Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Loratadine API Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Loratadine API Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Loratadine API Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Loratadine API Sales Quantity by Region (2018-2024) & (K MT)
Table 103. APAC Loratadine API Sales Quantity by Region (2024-2034) & (K MT)
Table 104. Middle East, Africa and Latin America Loratadine API Sales Quantity by Company (2018-2024) & (K MT)
Table 105. Middle East, Africa and Latin America Loratadine API Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Loratadine API Sales Quantity by Type (2018-2024) & (K MT)
Table 107. Middle East, Africa and Latin America Loratadine API Sales Quantity by Type (2024-2034) & (K MT)
Table 108. Middle East, Africa and Latin America Loratadine API Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Loratadine API Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Loratadine API Sales Quantity by Application (2018-2024) & (K MT)
Table 111. Middle East, Africa and Latin America Loratadine API Sales Quantity by Application (2024-2034) & (K MT)
Table 112. Middle East, Africa and Latin America Loratadine API Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Loratadine API Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Loratadine API Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Loratadine API Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Loratadine API Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Loratadine API Sales Quantity by Country (2018-2024) & (K MT)
Table 118. Middle East, Africa and Latin America Loratadine API Sales Quantity by Country (2024-2034) & (K MT)
Table 119. Merck Group Company Information
Table 120. Merck Group Description and Overview
Table 121. Merck Group Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 122. Merck Group Loratadine API Product and Services
Table 123. Merck Group Loratadine API SWOT Analysis
Table 124. Merck Group Recent Developments
Table 125. Cadila Pharmaceuticals Company Information
Table 126. Cadila Pharmaceuticals Description and Overview
Table 127. Cadila Pharmaceuticals Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 128. Cadila Pharmaceuticals Loratadine API Product and Services
Table 129. Cadila Pharmaceuticals Loratadine API SWOT Analysis
Table 130. Cadila Pharmaceuticals Recent Developments
Table 131. Morepen Company Information
Table 132. Morepen Description and Overview
Table 133. Morepen Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 134. Morepen Loratadine API Product and Services
Table 135. Morepen Loratadine API SWOT Analysis
Table 136. Morepen Recent Developments
Table 137. Ultratech India Limited Company Information
Table 138. Ultratech India Limited Description and Overview
Table 139. Ultratech India Limited Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 140. Ultratech India Limited Loratadine API Product and Services
Table 141. Ultratech India Limited Loratadine API SWOT Analysis
Table 142. Ultratech India Limited Recent Developments
Table 143. Vasudha Pharma Chem Company Information
Table 144. Vasudha Pharma Chem Description and Overview
Table 145. Vasudha Pharma Chem Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 146. Vasudha Pharma Chem Loratadine API Product and Services
Table 147. Vasudha Pharma Chem Loratadine API SWOT Analysis
Table 148. Vasudha Pharma Chem Recent Developments
Table 149. Hetero Drugs Ltd Company Information
Table 150. Hetero Drugs Ltd Description and Overview
Table 151. Hetero Drugs Ltd Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 152. Hetero Drugs Ltd Loratadine API Product and Services
Table 153. Hetero Drugs Ltd Loratadine API SWOT Analysis
Table 154. Hetero Drugs Ltd Recent Developments
Table 155. Mylan Company Information
Table 156. Mylan Description and Overview
Table 157. Mylan Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 158. Mylan Loratadine API Product and Services
Table 159. Mylan Loratadine API SWOT Analysis
Table 160. Mylan Recent Developments
Table 161. Changzhou Yabang Company Information
Table 162. Changzhou Yabang Description and Overview
Table 163. Changzhou Yabang Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 164. Changzhou Yabang Loratadine API Product and Services
Table 165. Changzhou Yabang Loratadine API SWOT Analysis
Table 166. Changzhou Yabang Recent Developments
Table 167. Shaanxi Hanjiang Company Information
Table 168. Shaanxi Hanjiang Description and Overview
Table 169. Shaanxi Hanjiang Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 170. Shaanxi Hanjiang Loratadine API Product and Services
Table 171. Shaanxi Hanjiang Loratadine API SWOT Analysis
Table 172. Shaanxi Hanjiang Recent Developments
Table 173. Inke, S.A. Company Information
Table 174. Inke, S.A. Description and Overview
Table 175. Inke, S.A. Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 176. Inke, S.A. Loratadine API Product and Services
Table 177. Inke, S.A. Loratadine API SWOT Analysis
Table 178. Inke, S.A. Recent Developments
Table 179. Argon Drugs Company Information
Table 180. Argon Drugs Description and Overview
Table 181. Argon Drugs Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 182. Argon Drugs Loratadine API Product and Services
Table 183. Argon Drugs Recent Developments
Table 184. Shenzhen Haibin Pharmaceutical Company Information
Table 185. Shenzhen Haibin Pharmaceutical Description and Overview
Table 186. Shenzhen Haibin Pharmaceutical Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 187. Shenzhen Haibin Pharmaceutical Loratadine API Product and Services
Table 188. Shenzhen Haibin Pharmaceutical Recent Developments
Table 189. Shenzhen Salubris Pharmaceuticals Company Information
Table 190. Shenzhen Salubris Pharmaceuticals Description and Overview
Table 191. Shenzhen Salubris Pharmaceuticals Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 192. Shenzhen Salubris Pharmaceuticals Loratadine API Product and Services
Table 193. Shenzhen Salubris Pharmaceuticals Recent Developments
Table 194. Changzhou Fangyuan Pharmaceutical Company Information
Table 195. Changzhou Fangyuan Pharmaceutical Description and Overview
Table 196. Changzhou Fangyuan Pharmaceutical Loratadine API Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 197. Changzhou Fangyuan Pharmaceutical Loratadine API Product and Services
Table 198. Changzhou Fangyuan Pharmaceutical Recent Developments
Table 199. Key Raw Materials Lists
Table 200. Raw Materials Key Suppliers Lists
Table 201. Loratadine API Distributors List
Table 202. Loratadine API Customers List
Table 203. Loratadine API Market Trends
Table 204. Loratadine API Market Drivers
Table 205. Loratadine API Market Challenges
Table 206. Loratadine API Market Restraints
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Loratadine API Product Picture
Figure 2. Global Loratadine API Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Loratadine API Market Share by Type in 2022 & 2034
Figure 4. USP Standards Grade Product Picture
Figure 5. EP Standards Grade Product Picture
Figure 6. Pharmaceutical Standards Grade Product Picture
Figure 7. Others Product Picture
Figure 8. Global Loratadine API Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Loratadine API Market Share by Application in 2022 & 2034
Figure 10. Loratadine Tablet
Figure 11. Loratadine Capsules
Figure 12. Loratadine Syrup
Figure 13. Dry Suspension
Figure 14. Others
Figure 15. Loratadine API Report Years Considered
Figure 16. Global Loratadine API Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Loratadine API Revenue 2018-2034 (US$ Million)
Figure 18. Global Loratadine API Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 19. Global Loratadine API Sales Quantity 2018-2034 (K MT)
Figure 20. Global Loratadine API Sales Quantity Market Share by Region (2018-2024)
Figure 21. Global Loratadine API Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Loratadine API Sales Quantity YoY (2018-2034) & (K MT)
Figure 23. North America Loratadine API Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Loratadine API Sales Quantity YoY (2018-2034) & (K MT)
Figure 25. Europe Loratadine API Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Loratadine API Sales Quantity YoY (2018-2034) & (K MT)
Figure 27. China Loratadine API Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Loratadine API Sales Quantity YoY (2018-2034) & (K MT)
Figure 29. APAC Loratadine API Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Loratadine API Sales Quantity YoY (2018-2034) & (K MT)
Figure 31. Middle East, Africa and Latin America Loratadine API Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Loratadine API Sales Quantity in 2022
Figure 33. The Top 10 and Top 5 Players Market Share by Loratadine API Revenue in 2022
Figure 34. Loratadine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Loratadine API Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Loratadine API Revenue Market Share by Type (2018-2034)
Figure 37. Global Loratadine API Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Loratadine API Revenue Market Share by Application (2018-2034)
Figure 39. North America Loratadine API Revenue Market Share by Company in 2022
Figure 40. North America Loratadine API Sales Quantity Market Share by Company in 2022
Figure 41. North America Loratadine API Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Loratadine API Revenue Market Share by Type (2018-2034)
Figure 43. North America Loratadine API Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Loratadine API Revenue Market Share by Application (2018-2034)
Figure 45. North America Loratadine API Revenue Share by Country (2018-2034)
Figure 46. North America Loratadine API Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Loratadine API Sales Quantity Market Share by Company in 2022
Figure 50. Europe Loratadine API Revenue Market Share by Company in 2022
Figure 51. Europe Loratadine API Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Loratadine API Revenue Market Share by Type (2018-2034)
Figure 53. Europe Loratadine API Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Loratadine API Revenue Market Share by Application (2018-2034)
Figure 55. Europe Loratadine API Revenue Share by Country (2018-2034)
Figure 56. Europe Loratadine API Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 58. France Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 62. China Loratadine API Sales Quantity Market Share by Company in 2022
Figure 63. China Loratadine API Revenue Market Share by Company in 2022
Figure 64. China Loratadine API Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Loratadine API Revenue Market Share by Type (2018-2034)
Figure 66. China Loratadine API Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Loratadine API Revenue Market Share by Application (2018-2034)
Figure 68. APAC Loratadine API Sales Quantity Market Share by Company in 2022
Figure 69. APAC Loratadine API Revenue Market Share by Company in 2022
Figure 70. APAC Loratadine API Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Loratadine API Revenue Market Share by Type (2018-2034)
Figure 72. APAC Loratadine API Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Loratadine API Revenue Market Share by Application (2018-2034)
Figure 74. APAC Loratadine API Revenue Share by Region (2018-2034)
Figure 75. APAC Loratadine API Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 80. India Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Loratadine API Sales Quantity Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Loratadine API Revenue Market Share by Company in 2022
Figure 83. Middle East, Africa and Latin America Loratadine API Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Loratadine API Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Loratadine API Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Loratadine API Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Loratadine API Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Loratadine API Revenue Share by Country (2018-2034)
Figure 89. Brazil Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Loratadine API Revenue (2018-2034) & (US$ Million)
Figure 94. Loratadine API Value Chain
Figure 95. Loratadine API Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed